Delivery Order SPE2DB22D1017-SPE2DB25FYPNG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,668.77 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's substantial role as a pharmaceutical supplier to federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,125.76 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Refresh Plus 0.5% eye drops (30-unit package). This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The contract specifies Conshohocken, Pennsylvania as the place of...
- The Defense Logistics Agency awarded a $1,548.00 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for Refresh Plus 0.5% Eye Drops (30-count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 11, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $3,715.27 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-unit package) on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,244.93 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Refresh Plus 0.5% eye drops (30-count units) with a contract value of $1,476.04. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, demonstrating...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,870.98 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-unit supply) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,112.13 to AmerisourceBergen Drug Corp on August 8, 2025, for Refresh Plus 0.5% eye drops (70 unit dose packages). This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The order is scheduled for completion by August 11, 2025, with performance at AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,155.39 to AmerisourceBergen Drug Corp on July 30, 2025, for Refresh Plus 0.5% eye drops (30-count packages). This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by July 31, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, supporting federal medical procurement requirements for military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on August 7, 2025, for Refresh Plus 0.5% eye drops in unit dose packaging (50 count). The contract is valued at $1,583.61 with a firm fixed price structure and an ultimate completion date of August 8, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPNGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-unit package) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, valued at $1,167.56, represents a non-competitive set-aside transaction and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle designed to supply pharmaceutical products and medical supplies to support military healthcare programs globally through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical supply contracts predominantly with the Defense Logistics Agency. The company's federal procurement history demonstrates consistent capability in delivering diverse pharmaceutical products and medical commodities through competitively awarded delivery orders with firm fixed pricing. This specific eye drops delivery order exemplifies the company's role in fulfilling routine medical supply requirements across the federal healthcare system, serving critical customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through its comprehensive DLA contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/29/25 |